PRESS RELEASE published on 09/24/2024 at 11:51, 1 year 8 months ago Original-Research: Pentixapharm Holding AG (von BankM AG): n.a. Pentixapharm Holding AG von BankM AG eingestuft. Präziser Theranostic-Ansatz mit validiertem Target. Potenzial in Präzisionsonkologie. Risikoadjustierte Bewertung des Eigenkapitals. Vollständige Analyse unter: http://www.more-ir.de/d/30855.pdf BankM AG Pentixapharm Holding AG Theranostic-Ansatz Präzisionsonkologie Bewertung Eigenkapital
BRIEF published on 09/23/2024 at 12:20, 1 year 8 months ago Pentixapharm Holding AG Sets Price Range for Planned IPO Frankfurt Stock Exchange Clinical Trials IPO Radiopharmaceuticals Pentixapharm
BRIEF published on 09/23/2024 at 12:20, 1 year 8 months ago Pentixapharm Holding AG fixe la fourchette de prix de son introduction en bourse Bourse De Francfort Essais Cliniques Introduction En Bourse Produits Radiopharmaceutiques Pentixapharm
PRESS RELEASE published on 09/23/2024 at 12:15, 1 year 8 months ago Pentixapharm Holding AG Sets Price Range for Planned IPO Pentixapharm Holding AG sets price range of EUR 4.70 to EUR 6.00 per share for planned IPO to fund product pipeline development in radioligand therapies IPO Financial Resources Price Range Pentixapharm Holding AG Radioligand Therapies
BRIEF published on 09/12/2024 at 15:05, 1 year 8 months ago Pentixapharm Holding AG Plans IPO on Frankfurt Stock Exchange Frankfurt Stock Exchange Cancer Treatment IPO Radiopharmaceuticals Phase III Trials
BRIEF published on 09/12/2024 at 15:05, 1 year 8 months ago Pentixapharm Holding AG envisage une introduction en bourse à Francfort Bourse De Francfort Introduction En Bourse Traitement Du Cancer Produits Radiopharmaceutiques Essais De Phase III
PRESS RELEASE published on 09/12/2024 at 15:00, 1 year 8 months ago Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange Pentixapharm Holding AG, a subsidiary of Eckert & Ziegler SE, plans IPO on the Prime Standard of the Frankfurt Stock Exchange, focusing on innovative radiopharmaceuticals for theranostics of various indications Frankfurt Stock Exchange IPO Radiopharmaceuticals Pentixapharm Holding AG Theranostics
Published on 05/29/2026 at 15:50, 3 hours 22 minutes ago Power Metallic Mines Announces Upsize of Brokered LIFE Offering for Gross Proceeds of up to C$30 Million
Published on 05/29/2026 at 14:30, 4 hours 42 minutes ago Sarama Completes Tranche 1 Equity Placement and ASX Cleansing Notice
Published on 05/29/2026 at 14:30, 4 hours 42 minutes ago Unusual Machines to Participate in June Investor Conferences
Published on 05/29/2026 at 14:20, 4 hours 52 minutes ago Ansell Announces Greenovation(TM) Awards for Sustainability Leadership and Waste Reduction
Published on 05/29/2026 at 13:59, 5 hours 13 minutes ago AIP Realty Trust Announces First Quarter 2026 Results
Published on 05/29/2026 at 18:50, 22 minutes ago EQS-Adhoc: fox e-mobility AG: Capital Increase and Debt Reduction at Fox Automotive Switzerland AG – Adjustment of Shareholding Value – Departure of Philippe Perret – Financial Reports – Annual General Meeting D
Published on 05/29/2026 at 18:30, 42 minutes ago EPIC Suisse AG: EPIC Suisse divests Vennes III property in Lausanne
Published on 05/29/2026 at 18:00, 1 hour 12 minutes ago Recticel Group versnelt groei in isolatiepanelen met geïntegreerde isothermische oplossingen na overname Isopanel NV
Published on 05/29/2026 at 18:00, 1 hour 12 minutes ago Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 15:38, 3 hours 34 minutes ago Déclaration d'actions et de droits de vote au 30.04.2026